Epidemiology and prevention of transfusion-associated human immunodeficiency virus transmission in sub-Saharan Africa

Vox Sanguinis

Volumn 72, Issue 2, 1997, Pages 85-92

  McFarland, William ^a,e   Mvere, David ^b   Shandera, Wayne ^c   Reingold, Arthur ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Blood Transfusion Service   (Zimbabwe)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

AFRICA; ARTICLE; BLOOD TRANSFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0031038187     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7220085.x     Document Type: Article

References (80)

1. Kimball AM, Berkeley S, Ngugi E, Gayle H: International aspeets of the AIDS/HIV epidemic. Annu Rev Public Health 1995;16:253-282.
2. Heymann SJ, Brewer TF: The problem of transfusion-associated acquired immunodeficiency syndrome in Africa: A quantitative approach. Am J Infect Control 1992;20:256-262.
3. Sondag D, Fournel JJ, Beal RW, Bontinck M, Fransen L: Sécurité transfusionnelle dans les pays en voie de développement. Rapport de la Réunion des Experts de la CEE, (report No. D/1992/6325/2). Wetteren, Task Force SIDA de la CCE, 1992.
4. N'tita I, Mulanga K, Dulat C, Lusamba D, Rehle T, Korte R, Jager H: Risk of transfusion-associated HIV transmission in Kinshasa, Zaire. AIDS 1991;5:437-439.
5. Davachi F: Pediatric HIV infection in Africa; in Essex M, Mboup S, Kanki P, Kalengayi M (eds): AIDS in Africa. New York, Raven Press, 1994, pp 439-462.
6. Colebunders R, Ryder R, Francis H, Nekwi W, Bahwe Y, Lebughe J, Ndilu M, Vercauteren G, Nseka K, Perriens J, van ser Stuft P, Quinn T, Piot P: Seroconversion rate, mortality, and clinical manifestations associated with the receipt of human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J Infect Dis 1991;164:450-456.
7. Soderberg S, Temihango W, Kadete C, Ekstedt B, Masawe A, Vahlne A, Horal P: Prevalence of HIV-1 infection in rural, semi-urban and urban villages in southwest Tanzania: Estimates from a blood-donor study. AIDS 1994;8:971-976.
8. Schulz R, Savarit D, Kadjo JC, Batter V, Kone N, La Ruche G, Bondurand A, De Cock K: Excluding blood donors at high risk of HIV infection in a west African city. BMJ 1993;307: 1517-1519.
9. Holzer BR, Egger M, Teusher T, Koch S, Mboya DM, Smith GD: Childhood anemia in Africa: To transfuse or not to transfuse? Acta Trop 1993;55:47-51.
10. Jager H, N'Galy B, Perriens J, Nseka K, Davaichi F, Kabeya C-M, Rauhaus G, Peyerl G, Ryder R, Rehle T: Prevention of transfusion-associated HIV transmission in Kinshasa, Zaire: HIV screening is not enough. AIDS 1990;4:571-574.
11. Lackritz EM, Ruebush TKI, Zucker JR, Adungosi JE, Were JBO, Campbell CC: Blood transfusion practices and blood-banking services in a Kenyan hospital. AIDS 1993;7:995-999.
12. Lackritz EM, Campbell CC, Ruebush TKI, Hightower A, Wakube W, Steketee R, Were J: Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992;340: 524-528.
13. Addo-Yobo EOD, Lovel H: How well are hospitals preventing iatrogenic HIV? A study of the appropriateness of blood transfusions in three hospitals in the Ashanti region, Ghana. Trop Doct 1991;21:162-164.
14. Jager H, Jersild C, Emmanuel JC: Safe blood transfusions in Africa. AIDS 1991;5(suppl 1): S163-S168.
15. Ryder RW: Difficulties associated with providing an HIV-free blood supply in tropical Africa. AIDS 1992;6:1395-1397.
16. Craighead IB, Knowles JK: Prevention of transfusion-associated HIV transmission with the use of a transfusion protocol for under 5s. Trop Doct 1993;23:59-61.
17. N'Galy B, Ryder RW: Epidemiology of HIV infection in Africa. J Acquir Immune Defic Syndr 1988;1:551-558.
18. Greenberg AE, Nguyen-Dihn P, Mann JM, Kabote N, Colebunders R, Francis H, Quinn T, Badoux P Lyamba B, Davaichi F: The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA 1988;259:545-549.
19. Foster S, Buve A: Benefits of HIV screening of blood transfusions in Zambia. Lancet 1995; 346:225-227.
20. Lackritz EM, Djomand G, Vetter KM, Zadi F, Diaby L, De Cock K: Beyond blood screening: Reducing unnecessary transfusions and improving laboratory service in Côte d'Ivoire (abstract No. WS-C11-2). IX International Conference on AIDS, Berlin, 1993.
21. Vos J, Gumodoka B, Ng'weshemi JZL, Kigadye FC, Dolmans WMV, Borgdorff MW: Are some blood transfusions avoidable? Trop Geogr Med 1993;45:301-303.
22. Gumodoka B, Vos J, Kigadye F, van Asten H, Dolmans WMV, Bordorff MW Blood transfusion practices in Mwanza region, Tanzania. AIDS 1993;7:387-392.
23. Piot P, Hams J: The epidemiology of HIV/ AIDS in Africa; in Lamptey P, Piot P (eds): The Handbook for AIDS Prevention in Africa. Durham, Family Health International, 1990, pp 1-15.
24. Carswell JW: HIV: Implications for blood transfusion and banking in Africa. Trop Doct 1990; 20:42-43.
25. Nzilambi N, Colebunders RL, Mann JM, Francis H, Nseka K, Curran JW: HIV blood screening in Africa: Are there no alternatives? (abstract W 46). Third International Conference on AIDS, Washington, 1987.
26. Mhalu SM, Ryder RW: Blood transfusion and AIDS in the tropics. Baillieres Clin Trop Med Commun Dis 1988;3:157-166.
27. Berkley S: Public health measures to prevent HIV spread in Africa: in Essex M, Mboup S, Kanki P, Kalengayi MR (eds): Aids in Africa. New York, Raven Press, 1994, pp 473-495.
28. HIV/AIDS Surveillance Report. Centers for Disease Control, June 1989, p 1.
29. HIV/AIDS Surveillance Report. Centers for Disease Control, June 1994, p 7.
30. Butler D: Concern over 'invisible problem' of HIV blood in developing countries. Nature 1994;369:429.
31. Hamerschlak N: AIDS risk and prevention in transfusions. Nat Immun Cell Growth Regul 1990;9:150-154.
32. Mann J, Tarantola DJM, Netter TW: The HIV pandemic: Status and trends; in Mann J, Tarantola DJM, Netter TW (eds): AIDS in the World. Cambridge, Harvard University Press, 1992, pp 109-132.
33. Shaffer N, Hedberg K, Davaichi F, Lyamba B, Breman JG, Masisa OS, Hightower A, Nguyen-Dihn P: Trends and risk factors for HIV-1 sero-positivity among outpatient children, Kinshasa, Zaire. AIDS 1990;4:1231-1236.
34. Mann JM, Francis H, Davachi F, Baudoux P, Quinn T, Nzilambi N, Bosenge N, Colebunders R, Kabote N, Piot P: Human immunodeficiency virus seroprevalence in pediatric patients 2-14 years of age at Mama Yemo Hospital, Kinshasa, Zaire. Pediatrics 1986;78:4.
35. Watson-Williams EJ: Development of EDF safe blood programmes in Africa (abstract THRT 021). VIII International Conference on AIDS in Africa. Marrakech, 1993.
36. Emmanuel J, Britten A: Reducing HIV transmission through blood; in Lamptey P, Piot P (eds): The Handbook for AIDS Prevention in Africa. Durham, Family Health International, 1990; pp 71-81.
37. Beal R: Transfusion science and practice in developing countries: '...A high frequency of empty shelves...'. Transfusion 1993;33:276-278.
38. van Dam CJ, Sondag-Thull D, Fransen L: The provision of safe blood-policy issues in the prevention of human immunodeficiency virus transmission. Trop Doct 1992;22:20-23.
39. Harry TO, Moses AE, Ola TO, Obi SO, Bajani MD: Increasing risk of transfusion-associated AIDS as the pandemic spreads: Experience in Maiduguri, Nigeria. J Trop Med Hyg 1993;96: 131-133.
40. Hewitt PE, Barbara JAJ, Contreras M: Donor selection and microbial screening. Vox Sang 1994;67(suppl 5):14-19.
41. Behets F, Bertozzi S, Kasali M, Kashanuka M, Atikala L, Brown C, Ryder R, Quinn T: Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 1990;4:737-741.
42. Gibbs WN, Corcoran P: Improving safety of blood transfusion in developing countries. Vox Sang 1994;67(suppl 3):61-66.
43. Khamisi J: AIDS panic: HIV 'is rife in Kenyan blood supply'. The Argus. Capetown, 11 May 1995, p 3.
44. Mahomed K, Kasule J, Makuyana D, Moyo S, Mbidzo M, Tswana S: Seroprevalence of HIV infection amongst antenatal women in greater Harare, Zimbabwe. Cent Afr J Med 1991;37: 322-325.
45. AIDS worries ZISCO. Herald. Harare, 27 November 1990.
46. Allen S, Lindau C, Serufilia A, van de Perre P, Rundle A, Nsengumuremyi F, Carael M, Schwalbe J, Hulley S: Human Immunodeficiency virus infection in urban Rwanda: Demographic and behavioral correlates in a representative sample of childbearing women. JAMA 1991;266:1657-1663.
47. Leroy V, van de Perre P, Lepage P, Saba J, Nsengumuremyi F, Simonon A, Karita E, Msellati P, Salamon R, Dabis F: Seroineidence of HIV-1 infection in African women of reproductive age: A prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS 1994;8:983-986.
48. Center for International Research, US Bureau of the Census; HIV AIDS Surveillance Data Base 1993.
49. Savarit D, De Cock KM, Schutz R, Konate S, Lackritz E, Bondurand A: Risk of HIV infection from transfusion with blood negative for HIV antibody in a West African city. BMJ 1992; 305:498-501.
50. Emmanuel JC, Bassett MT, Smith HJ, Jacobs JA: Pooling of sera for human immunodeficiency virus (HIV) testing: An economical method for use in developing countries. J Clin Pathol 1988;41:582-585.
51. Sitas F, Fleming AF, Morris J: Residual risk of transmission of HIV through blood transfusion in South Africa. S Afr Med J 1994;84:142-144.
52. Busch MP: HIV and blood transfusions: Focus on seroconversion. Vox Sang 1994;67(suppl 3): 13-18.
53. Kanter MH, Petz L: The validity of statistical analyses in the transfusion medicine literature with specific comments concerning studies of the comparative safety of units donated by autologous, designated and allogenic donors. Transfus Med 1995;5:91-95.
54. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
55. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP, Petersen LR: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-1725.
56. Watson-Williams EJ, Kataaha P, Senyonga P, Kyeyune D: Cost-effectiveness of Uganda blood programme (abstract No. THRT 021). X International Conference on AIDS. Yokohama, 1994.
57. McFarland W, Kahn JG, Katzenstein D, Mvere D, Shamu R: Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe. J Acquir Immune Defic Syndr 1995;9:183-192.
58. Over M, Piot P: Health sector priorities review: HIV infection and sexually transmitted diseases; in Jamison DT, Moseley WH (eds): Disease Control Priorities in Developing Countries. New York, Oxford University Press, 1993, pp.
59. Emmanuel JC: Blood transfusion systems in economically restricted countries. Vox Sang 1994;67(suppl 3):267-269.
60. Leikola J, Contreras M: Overview of issues and problems facing blood transfusion services. Vox Sang 1994;67(suppl 5):1-3.
61. Seidel K, Inbondit S, Lyambo S: Selection criteria for blood donors with respect to HIV infection (abstract WOP 29). VIII International Conference on AIDS in Africa. Marrakech, 1993.
62. Emeribe AO, Ejele AO, Attai EE, Usanga EA: Blood donation and patterns of use in southeastern Nigeria. Transfusion 1993;33:330-332.
63. Mvere D: Safe blood and blood products. Module 1: Safe blood donation. Report WHO/GPA/ CNP/93.2C. Geneva, World Health Organization, 1993.
64. Bassett MT, Latif AS, Katzenstein DA, Emmanuel JC: Sexual behavior and risk factors for HIV in a group of male factory workers who donated blood in Harare, Zimbabwe. J Acquir Immune Dcfic Syndr 1992;5:556-559.
65. Moses S, Plummer A: Health education, counselling and the underlying causes of the HIV epidemic in sub-Saharan Africa. AIDS Care 1994;6:123-127.
66. Simonsen JN, Cameron DW, Gayinka MN, Ndinya-Achola J, D'Costa L, Karasira P, Cheang M, Ronald AR, Piot P, Plummer F: Human immunodeficiency virus infection among men with sexually transmitted diseases: Experience from a center in Africa. N Engl J Med 1988; 319:274-278.
67. Lallemant M, Lallemant-Le Coeur S, Cheynier D, Nzingoula S, Jourdain G, Sinet M, Dazza M, Larouze B: Characteristics associated with HIV-1 infection in pregnant women in Brazzaville, Congo. J Acquir Immune Defic Syndr 1992;5:279-285.
68. Pison G, Le Guenno B, Lagarde E, End C, Seck C: Seasonal migration: A risk factor for HIV infection in rural Senegal. J Acquir Immune Defic Syndr 1993;6:196-200.
69. Kane F, Alary M, Ndoye I, Coll A, M'boup S, Gueye A, Kanki P, Joly J: Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS 1993;7:1261-1265.
70. Carswell JW, Lloyd G, Howells J: Prevalence of HIV-1 in east African lorry drivers. AIDS 1989; 3:759-761.
71. Bwayo J, Plummer F, Omari M, Mutere A, Ndinya-Achola J, Velentgas P, Kreis J: Human immunodeficiency virus infection in long-distance truck drivers in East Africa. Arch Intern Med 1994;154:1391-1396.
72. Berkley S, Widy-Wirski R, Okware SI, Downing R, Linnan M, White K, Sempala S: Risk factors associated with HIV infection in Uganda. J Infect Dis 1989;160:22-30.
73. Nyamongo J, Mitchcll J, Tukei PM, Newton P, Lux L: Use of a blood donor survey to develop deferral guidelines and selective recruitment criteria (abstract MC3350). VII International Conference on AIDS. Florence, 1991.
74. Banura C, Hom D, Houser HB: Factors associated with HIV-1 infection among blood donors at three stations in Uganda (abstract WS-C11-3. IX International Conference on AIDS. Berlin, 1993.
75. Jacobs B, Berege ZA, Schalula PJJ, Klokke AH: Secondary school students: A safer blood donor population in an urban area with high HIV prevalence in East Africa. East Afr Med J 1994;71:720-723.
76. Rowe AW: Cryopreservation of red blood cells. Vox Sang 1994;67(suppl 3):201-206.
77. Corash L: Inactivation of viruses in human cellular blood components. Vox Sang 1994; 67(suppl 3):211-216.
78. Kitayaporn (II) D, Bejrachandra S, Chongkolwatana V, Chandanayingyong D, Weniger BG: Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand. Transfusion 1994;34: 154-157.
79. Le Pont F, Costagliola D, Rouzioux C, Valleron AJ: How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests? Transfusion 1995;35:542-547.
80. Pimay P, Abimecy S, Komate S, Syransy L, Bontex W, Coulibaly Y, Hyda J, Bondurand A: Risque transfusionnel résiduel au CNTS d'Abidjan: Estimation du risque de prélever au donneur de sang régulier durant la phase de préséroconversion (abstract TuC581). IX International Conference on AIDS and STD in Africa. Kampala, 1995.